Pre-treatment serum albumin and mutational burden as biomarkers of response to immune checkpoint blockade.

NPJ Precis Oncol · 2022 · PMC8990074 · PMID 35393553

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

The Albumin-H group showed a clear trend of higher response rates than the Albumin-L group in pan-cancer and subgroup analyses (Fig. 1b ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.